1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline

1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline
Clinical data
Other names"Compound 106"; 6-Chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-β-carboline; 1-(2,4,5-OMePh)-6-Cl-THβC
Drug classSerotonin receptor modulator; Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonin 5-HT2C receptor agonist
ATC code
  • None
Identifiers
  • 6-chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC20H21ClN2O3
Molar mass372.85 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1C2C3=C(CCN2)C4=C(N3)C=CC(=C4)Cl)OC)OC
  • InChI=1S/C20H21ClN2O3/c1-24-16-10-18(26-3)17(25-2)9-14(16)19-20-12(6-7-22-19)13-8-11(21)4-5-15(13)23-20/h4-5,8-10,19,22-23H,6-7H2,1-3H3
  • Key:RJHMAXLLXKUOBW-UHFFFAOYSA-N

1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline, also known as 6-chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-β-carboline, is a serotonin receptor modulator of the β-carboline family.[1] It is a ring-substituted derivative of the β-carboline tryptoline (THβC) and a simplified analogue of the heteroyohimbine alkaloid alstonine.[1]

Pharmacology

Pharmacodynamics

1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline acts as a highly potent full agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors.[1] Its EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) values were 1.7 nM (98.4%) at the serotonin 5-HT2A receptor, 0.50 nM (97.5%) at the serotonin 5-HT2B receptor, and 0.58 nM (96.7%) at the serotonin 5-HT2C receptor.[1] The drug was one of the most potent serotonin 5-HT2A receptor agonists of a large series of assessed tryptoline derivatives.[1]

1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline's potent serotonin 5-HT2 receptor agonism is in notable contrast to other simpler β-carbolines like harmine and harmaline, which have been found to be inactive as serotonin 5-HT2A receptor agonists even at very high concentrations.[2][3][4] Similarly, tryptoline itself shows very low affinity for serotonin 5-HT2 receptors.[5][6][7]

In addition to the serotonin 5-HT2 receptors, 1-(2,4,5-trimethoxyphenyl)-6-chlorotryptoline shows variable but mostly high affinity for most other serotonin receptors (Ki = 2.50–1,493 nM).[1] Interactions at other receptors have also been reported.[1]

Chemistry

Synthesis

The chemical synthesis of 1-(2,4,5-trimethoxyphenyl)-6-chlorotryptoline has been described.[1]

Analogues

A large number of analogues of 1-(2,4,5-trimethoxyphenyl)-6-chlorotryptoline have been described.[1]

History

1-(2,4,5-Trimethoxyphenyl)-6-chlorotryptoline was first described in the scientific literature by Meghan J. Orr and colleagues in 2022.[1]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 Orr MJ, Cao AB, Wang CT, Gaisin A, Csakai A, Friswold AP, et al. (April 2022). "Discovery of Highly Potent Serotonin 5-HT2 Receptor Agonists Inspired by Heteroyohimbine Natural Products". ACS Medicinal Chemistry Letters. 13 (4): 648–657. doi:10.1021/acsmedchemlett.1c00694. PMC 9014500. PMID 35450369.
  2. ↑ Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA (December 2003). "Binding of beta-carbolines at 5-HT(2) serotonin receptors". Bioorganic & Medicinal Chemistry Letters. 13 (24): 4421–4425. doi:10.1016/j.bmcl.2003.09.027. PMID 14643338.
  3. ↑ Rabin RA, Regina M, Doat M, Winter JC (May 2002). "5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens". Pharmacol Biochem Behav. 72 (1–2): 29–37. doi:10.1016/s0091-3057(01)00720-1. PMID 11900766.
  4. ↑ Rolquin JD (3 May 2022). "Examining Ayahuasca Constituents at 5-HT2A Receptors in Search of Antidepressant Action". VCU Scholars Compass. Retrieved 7 April 2026.
  5. ↑ Bojarski AJ, Cegła MT, Charakchieva-Minol S, Mokrosz MJ, Maćkowiak M, Misztal S, et al. (April 1993). "Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines" (PDF). Die Pharmazie. 48 (4): 289–294. PMID 8321880. Archived from the original on 2026-04-04. Retrieved 2026-04-04.{{cite journal}}: CS1 maint: bot: original URL status unknown (link)
  6. ↑ Taylor EW, Nikam S, Weck B, Martin A, Nelson D (October 1987). "Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites". Life Sciences. 41 (16): 1961–1969. doi:10.1016/0024-3205(87)90749-1. PMID 3657392.
  7. ↑ Cascio CS, Kellar KJ (November 1982). "Tetrahydro-beta-carbolines: affinities for tryptamine and serotonergic binding sites". Neuropharmacology. 21 (11): 1219–1221. doi:10.1016/0028-3908(82)90185-x. PMID 7177348.